However, the market is expected to grow significantly between 2022 and 2032, with a projected growth rate of 7%, which is ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

Alzheimer’s disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This process results in deterioration of muscle strength in the limbs and bulbar ...

The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE) builds on prior work by Putrino and his colleagues at Mount Sinai.

Alzheimer’s disease may damage the brain in two phases, according to new research published in Nature Neuroscience on Monday.

Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by achieving positive proof-of-mechanism in an ...

With the perpetual rise of technology and the proliferation of AI, we are moving faster than ever. New inventions have accelerated nearly every aspect of our lives, including medicine. In 2023, the ...

LVS Advisory discusses an investment they made in Medpace in the third quarter of 2024. Click here to read more about their ...